Ryanair CEO: 12-18 months for Boeing to eliminate delivery backlog-June 2024-www.financetom.com

Ryanair CEO: 12-18 months for Boeing to eliminate delivery backlog

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Ryanair CEO: 12-18 months for Boeing to eliminate delivery backlog

Apr 24, 2024 2:49 AM

LONDON, April 24 (Reuters) - Europe's biggest airline

Ryanair expects Boeing ( BA ) to take between 12 and 18

months to eliminate backlogs in its aircraft deliveries, group

chief executive Michael O'Leary told reporters at an event in

London.

Previous page： Global Atomic Says Situation in Niger Improving; Dasa Project Expected to Start Production in 2026 Next page： Dye & Durham Board Resigns, Appoints Engine Capital, OneMove Nominees to the Board

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Global Atomic Says Situation in Niger Improving; Dasa Project Expected to Start Production in 2026

Dec 17, 2024

08:28 AM EST, 12/17/2024 (MT Newswires) -- Global Atomic ( GLATF ) said Tuesday that the geopolitical situation in Niger continues to improve and expects the Dasa uranium project to begin production in the first quarter of 2026. Global Atomic ( GLATF ) said the government is providing full support for SOMIDA, the company's Niger operating subsidiary, and operations at...

Dye & Durham Board Resigns, Appoints Engine Capital, OneMove Nominees to the Board

Dec 17, 2024

08:25 AM EST, 12/17/2024 (MT Newswires) -- Dye & Durham ( DYNDF ) on Tuesday said the entire board of directors has resigned, adding that shareholders have made their views clear based on preliminary tabulation of proxies. The company has appointed Engine Capital nominees: Arnaud Ajdler, Hans Gieskes, Tracey Keates, Ritu Khanna, Anthony Kinnear, and Sid Singh, and, OneMove Capital...

Tenaya Says TN-201 Gene Therapy Well Tolerated in Initial Hypertrophic Cardiomyopathy Trial Patients

Dec 17, 2024

08:26 AM EST, 12/17/2024 (MT Newswires) -- Tenaya Therapeutics ( TNYA ) said Tuesday that preliminary data from the first cohort of three patients in a phase 1b/2 trial showed that its TN-201 gene therapy was well tolerated, with no cardiac toxicities or severe adverse effects. TN-201 is being developed for the potential treatment of MYBPC3-associated hypertrophic cardiomyopathy, a condition...

Morgan Stanley Partners with Wise for Cross-Border Payment Services

Dec 17, 2024

08:27 AM EST, 12/17/2024 (MT Newswires) -- Morgan Stanley ( MS ) has selected payments platform Wise to support foreign exchange settlement services for corporate clients, enabling faster cross-border payments, Wise said Tuesday. Financial terms were not provided. Wise said this marks the first time an investment bank has integrated the Wise Platform for corporate payment capabilities. Morgan Stanley (...